-+ 0.00%
-+ 0.00%
-+ 0.00%

Jazz Pharmaceuticals Reports Phase 3 Success for Ziihera in First-Line HER2+ Metastatic GEA

Reuters·01/06/2026 18:33:05

Please log in to view news